Comparative Pharmacology
Head-to-head clinical analysis: CUPRIC CHLORIDE IN PLASTIC CONTAINER versus CUPRIC SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CUPRIC CHLORIDE IN PLASTIC CONTAINER versus CUPRIC SULFATE.
CUPRIC CHLORIDE IN PLASTIC CONTAINER vs CUPRIC SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Copper is an essential trace element that serves as a cofactor for numerous enzymes, including cytochrome c oxidase, superoxide dismutase, ceruloplasmin, lysyl oxidase, and dopamine beta-hydroxylase. It is critical for mitochondrial respiration, antioxidant defense, connective tissue cross-linking, neurotransmitter synthesis, and iron homeostasis. Cupric chloride provides ionic copper for these physiological processes.
Copper is an essential trace element that serves as a cofactor for various enzymes involved in iron metabolism, connective tissue formation, and antioxidant defense. Cupric sulfate replaces copper in deficient states, enabling proper erythropoiesis, neurological function, and collagen synthesis.
0.5-2.5 mg copper per day intravenously as a supplement to parenteral nutrition.
For copper supplementation in total parenteral nutrition: 0.3-0.5 mg intravenously daily. For topical antifungal/antibacterial use: apply 2% solution or 0.1% ointment to affected area twice daily. For emetic use: 0.5-2 mg orally as a single dose.
None Documented
None Documented
Terminal elimination half-life of copper is approximately 2-4 weeks (13-28 days) in humans, reflecting slow turnover from tissue stores, particularly liver and brain. This long half-life is clinically important for cumulative toxicity risk.
Terminal elimination half-life of copper is 12-24 hours for the rapid phase, but a slower phase of 3-5 days reflects redistribution from tissues; clinical context: used for copper deficiency or as an emetic.
Primarily renal; approximately 80% of absorbed copper is excreted in bile, with fecal loss accounting for the majority (about 80-90%) of total elimination. Urinary excretion is minimal (<5%) under normal conditions.
Primarily fecal (biliary excretion of copper) ~80%; renal excretion accounts for ~2-5% of a dose under normal conditions; small amounts lost in sweat and desquamated skin.
Category C
Category C
Mineral Supplement
Mineral Supplement